Posted:
3/18/2025, 5:00:00 PM
Location(s):
Sydney, New South Wales, Australia ⋅ New South Wales, Australia
Experience Level(s):
Junior ⋅ Mid Level
Field(s):
Operations & Logistics ⋅ Sales & Account Management
Insulet started in 2000 with an idea and a mission to enable our customers to enjoy simplicity, freedom and healthier lives through the use of our Omnipod® product platform. In the last two decades we have improved the lives of hundreds of thousands of patients by using innovative technology that is wearable, waterproof, and lifestyle accommodating.
We are looking for highly motivated, performance driven individuals to be a part of our expanding team. We do this by hiring amazing people guided by shared values who exceed customer expectations. Our continued success depends on it!
Job Title: Finance Associate
Department: Commerical
Manager/Supervisor: Com Ops Manager
Position Overview:
Insulet is a global, innovative health care brand experiencing fast, global growth, expanding into Asia Pacific looking to disrupt the Insulin delivery Industry. This Australia based role offers an exciting opportunity for a Finance Associate. The purpose of this business-critical role is to be responsible for the reconciliation for the payments of funds from numerous agencies, investigation of these payments and assist with all back-end processes and controls to support Insulet reimbursement model. Success in this role will be accomplished through ability to quickly establish a rapport with business stakeholder both internal and external, be highly organized with a keen attention to detail, communicate effectively, learn quickly, and solve problems. The Finance Associate reports directly to the Commercial Operations Manager and works closely and collaboratively with the business, both in Australia and in Europe.
Responsibilities:
Skills/Competencies:
Education and Experience:
Website: https://insulet.com/
Headquarter Location: Bedford, Massachusetts, United States
Employee Count: 501-1000
Year Founded: 2000
IPO Status: Private
Last Funding Type: Post-IPO Debt
Industries: Biotechnology ⋅ Diabetes ⋅ Health Care ⋅ Medical Device